São Paulo, June 2025 – For the seventh year, Eurofarma was a standout in the Best in ESG awards, promoted by Exame Magazine. The company was the only pharmaceutical firm highlighted in the category, which also includes beauty companies. This recognition reaffirms the company's continuous commitment to ESG best practices, one of the five priority dimensions that guide its medium-term global objectives and help focus routine and work plans. The company is the only representative of the pharmaceutical sector to reach this milestone in the awards, reinforcing its consistent performance and leadership on the subject.

The awards ceremony took place on Tuesday night, the 25th, in São Paulo, gathering representatives from companies that stood out for their sustainable initiatives.

"Our journey of sustainability and maturity was only accompanied by external recognition because, in 2008, when we created our First Master Plan, we linked ESG themes to the company's global strategic planning. With investment and performance indicators in social, environmental, and governance fronts, we managed to advance connected to the business in our operations both inside and outside the country. We defined goals that were rolled out to the entire company and took on public commitments based on our values and market best practices", says Maria del Pilar Muñoz, Vice President of Sustainability and New Business at Eurofarma.

Eurofarma ESG
In 2024 alone, R$ 165.4 million was invested in ESG initiatives, a 54% increase compared to the previous year. The main focuses were:

• Humanitarian aid: R$ 77.5 million
• Environment: R$ 44.7 million
• Education: R$ 27.5 million
• Social actions: R$ 15.7 million

Among the social highlights is the work of the Eurofarma Institute, which benefited over 21,000 people with scholarships, technical courses, and Enem preparation programs; and the Lactare project, focused on human milk donation, which broke a record in 2024 with 4,400 liters collected and nearly 2,000 premature babies served.

In the area of health innovation, the company maintains a partnership with the healthtech PBSF for neonatal brain neuromonitoring, which has already totaled 36,000 hours of monitoring.

In environmental management, Eurofarma achieved 90% renewable electricity use and reduced greenhouse gas emissions by 48% (Scope 2). The company also expanded water reuse practices to its operations in Colombia and Guatemala, totaling over 54,000 m³ of reused water in 2024.

The pharmaceutical company also stands out in diversity and inclusion, with 50% of women in senior leadership and 43% of external hires composed of Black and Brown (Pardo) individuals. It was a pioneer in forming a 100% PwD (People with Disabilities) digital team and is certified as an Age Friendly Employer, with 12% of employees over the age of 50.

To learn more about all the company's initiatives on ESG fronts, access the 2025 Sustainability Report (base year 2024).